

Transfer of Certolizumab in Breast Milk Not a Concern
TNF Inhibitor Tied to Lower Cardiovascular Risk in Psoriasis
TNF Blocking Drugs Persist in Infants after Exposure In-Utero

• By Thomas R. Collins
• By Reuters Staff
• By Lorraine L. Janeczko
• By Anne Harding
• By Laura Newman
• By Laura Newman
• By Lorraine L. Janeczko
• By Richard Quinn
• By Lara C. Pullen, PhD
The Foundation is the largest private funding source for rheumatology research and training in the U.S.
Learn more about the ACR’s public awareness campaign and how you can get involved. Help increase visibility of rheumatic diseases and decrease the number of people left untreated.
Don’t miss rheumatology’s premier scientific meeting for anyone involved in research or the delivery of rheumatologic care or services.